Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
HIMS
Stock Latest News
Market News
Hims & Hers Health (HIMS) Shares Spike with Compounded Drug Strategy for GLP-1s
2d ago
LLY
NVO
Premium
The Fly
Hims & Hers to keep offering compounded Ozempic, Wegovy, WSJ reports
6d ago
LLY
NVO
Premium
Market News
Hims & Hers’ Weight-Loss Empire Hits a Gut-Wrenching Barrier
7d ago
LLY
NVO
Premium
The Fly
Hims & Hers price target raised to $22 from $21 at BofA
8d ago
HIMS
Premium
Ratings
Sell Rating for Hims & Hers Health Amid Slowing Core Business Growth and Legal Challenges
8d ago
HIMS
Premium
Market News
Hims & Hers Health’s (HIMS) App Downloads Surged in February, Says Top Analyst
8d ago
HIMS
Premium
The Fly
FDA voices ‘concerns’ with unapproved GLP-1 drugs used for weight loss
8d ago
LLY
NVO
Premium
The Fly
Hims & Hers app download pace accelerated in February, says Morgan Stanley
9d ago
HIMS
Premium
Ratings
Hims & Hers Health: Balancing Growth Momentum with Competitive Challenges
9d ago
HIMS
Premium
Market News
‘Don’t Buy the Dip,’ Says Morgan Stanley About Hims & Hers Stock
11d ago
HIMS
Premium
Market News
Hims & Hers (HIMS) Investors Pulling Their Hair Out Over Pills Side-Effects
12d ago
HIMS
Premium
The Fly
Telehealth companies aggressively marketing hair-loss medicine to men, WSJ says
13d ago
MRK
OGN
Premium
Ratings
Cautious Outlook on Hims & Hers Health Amid Aggressive Revenue Targets and Competitive Challenges in Weight Loss Market
14d ago
HIMS
Premium
Market News
Citi Sticks to Sell Rating on Hims & Hers (HIMS) Stock as FDA Ruling Clouds Outlook
15d ago
LLY
HIMS
Premium
The Fly
FDA update could extend Hims & Hers’ compounding timeline, says BofA
15d ago
HIMS
Premium
Market News
Hims & Hers Stock (HIMS) Soars on Plans to Shutter Acne Treatment Unit
16d ago
NVO
HIMS
Premium
Weekend Updates
Major Stock Moves: Duke, Booking, Halliburton, Hims & Hers, Innovative
18d ago
DUK
HAL
Premium
Ratings
Hims & Hers Health Faces Competitive and Regulatory Challenges Amid Novo Nordisk’s New Offering and FDA Developments
19d ago
HIMS
Premium
The Fly
Citi sees Hims & Hers trading down on Texas court ruling
20d ago
HIMS
Premium
The Fly
BofA says injunction denial ‘indirect negative’ for Hims & Hers
20d ago
LLY
NVO
Premium
The Fly
Hims & Hers lower after judge denies compounders’ motion for injunction
20d ago
LLY
NVO
Premium
The Fly
Novo takes ‘direct shot’ at Hims & Hers with NovoCare , says Citi
20d ago
LLY
NVO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
